Eli Lilly and Novo are preparing to announce new drug pricing deals with the White House, including for their blockbuster weight loss drugs. Blackstone Life Sciences will pay Merck $700 million for ...

MONTRÉAL, QC / ACCESS Newswire / November 6, 2025 / Valsoft Corporation Inc. ("Valsoft"), a Canadian company specializing in the acquisition and development of vertical market software businesses, ...

Rootstock Software, a leading provider of cloud ERP for product companies, today announced the establishment of Rootstock Software India Private Limited (Rootstock India), a wholly owned subsidiary ...

Discover key insights from Schrödinger’s Q3 2025 earnings: revenue growth, updated guidance, cost reductions, and long-term market opportunities.

PainReform Ltd. (Nasdaq: PRFX), today announced that DeepSolar, its solar energy business unit developing next-generation AI-driven solar analytics, was recently featured in a Watchlist Interview ...

Whether you're recruiting new talent or looking to make payroll more efficient, these companies can help reach your goals.

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, ...

In February 2025, we announced a 2025 share buyback program of up to €1 billion. The 2025 program was completed on November 3, 2025, two months earlier than originally planned. This followed the ...

CFO and COO Mark Hirschhorn reported, "in the third quarter, we delivered results ahead of expectations for both revenue and adjusted EBITDA, reflecting stronger subscription retention, increased ...

Companies this past month announced many new products and services that use artificial intelligence to automate complex processes, secure data and improve care coordination and interoperability ...

Copenhagen, Denmark, November 4, 2025, (GLOBE NEWSWIRE) – BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR), today announced an update on its ongoing adult clinical study in the US.

Mechelen, Belgium; November 3, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present new and updated data for CAR T-cell therapy candidate, GLPG51011, at the ...